Frequency and estimated costs of ten low-value practices in the Spanish primary care: a retrospective study


Por: Cheikh A, Caro Mendivelso J, Carrillo I, Astier-Peña MP, Olivera G, Silvestre C, Nuín M and Mira JJ

Publicada: 3 jul 2022 Ahead of Print: 1 ene 2022
Resumen:
Background The frequency of low-value practices (LVPs) in the healthcare system is a worldwide challenge. This study aimed to evaluate the LVPs trend in Spanish primary care (PC), its frequency in both sexes, and estimate its related extra cost. Methods A multicentric, retrospective, and national research project was conducted. Ten LVPs highly frequent and potentially harmful for patients were analyzed (majority of them related to prescription). Algorithms were applied to collect the data from 28,872,851 episodes registered into national databases (2015-2017). Results LVPs registered a total of 7,160,952 (26.5%) episodes plus a total of 259,326 avoidable PSA screening tests. In adults, a high frequency was found for inadequate prescription of paracetamol antibiotics, and benzodiazepines . Women received more jeopardizing practices (p <= 0.001). Pediatrics presented a downward of antibiotic and paracetamol-ibuprofen prescription combination. The estimated extra cost was close to euro292 million (2.8% of the total cost in PC). Conclusion LVPs reduction during the analyzed period was moderate compared to studies following 'Choosing Wisely list' of LVPs and must improve to reduce patient risk and the extra related costs.

Filiaciones:
Cheikh A:
 Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO), Sant Joan d'Alacant, Spain

Caro Mendivelso J:
 Agency for Health Quality and Assessment of Catalonia (AQuAS), Barcelona, Spain

 CIBER Epidemiology and Public Health (CIBERESP), Barcelona, Spain

:
 Department of Health Psychology, Miguel Hernandez University, Elche, Spain

Astier-Peña MP:
 Family and Community Medicine, Universitas Health Centre, Zaragoza I Sector, Aragonese Health Service (SALUD), Zaragoza, Spain

 University of Zaragoza, Aragon Health Research Institute (IISA), Zaragoza, Spain

Olivera G:
 Hospital Clínico San Carlos, Madrid Health Service, Madrid, Spain

Silvestre C:
 Healthcare Effectiveness and Safety Service, Navarre Health Service-Osasunbidea, Pamplona, Spain

Nuín M:
 Healthcare Effectiveness and Safety Service, Navarre Health Service-Osasunbidea, Pamplona, Spain

:
 Department of Health Psychology, Miguel Hernandez University, Elche, Spain

 Health District Alicante-Sant Joan, Alicante, Spain

 REDISSEC, Spain
ISSN: 14740338





EXPERT OPINION ON DRUG SAFETY
Editorial
TAYLOR & FRANCIS LTD, 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 21 Número: 7
Páginas: 995-1003
WOS Id: 000744699500001
ID de PubMed: 35020555

MÉTRICAS